Principia Biopharma Inc (NASDAQ:PRNB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Thompson Other companies: Aspen Neuroscience, Inc. (General Partner · Since at least Nov 2, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Edgewise Therapeutics, Inc. (Chairman and Co-Founder · Since at least Mar 25, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020); Corvus Pharmaceuticals, Inc. (CO-FOUNDER · Since at least Mar 22, 2016); Janux Therapeutics, Inc. (Director · Jun 10, 2021 – Jun 14, 2022 · Past); Decibel Therapeutics Inc (Director · Feb 11, 2021 – Jun 17, 2022 · Past); PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Jun 2, 2021 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jun 4, 2018 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Anthera Pharmaceuticals Inc (Director · Feb 1, 2011 – May 8, 2012 · Past); Trubion Pharmaceuticals Inc (President and CEO, Director · Oct 17, 2006 – Aug 27, 2009 · Past) | Director · Sep 13, 2018 – Sep 13, 2018 · Past |
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Adverum Biotechnologies Inc (Director · Since at least Mar 14, 2017); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · Jun 11, 2019 – Sep 28, 2020 · Past |
| Alan B. Colowick Other companies: Alumis Inc. (Managing Director, AyurMaya, an affiliate of Matrix Capital Management · Since at least Jun 27, 2024); Maze Therapeutics, Inc. (Director · Jan 30, 2025 – Jan 30, 2025 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 4, 2023 · Past); Harpoon Therapeutics Inc (Director · Mar 24, 2021 – Apr 1, 2023 · Past); Personalis, Inc. (Director · Jun 19, 2019 – May 17, 2023 · Past); Dimension Therapeutics (Director · Oct 21, 2015 – Nov 7, 2017 · Past); Achaogen Inc (Director · Mar 11, 2015 – Jun 14, 2017 · Past); Geron Corporation (President, Oncology · Oct 16, 2006 – Jan 2, 2008 · Past); Threshold Pharmaceuticals Inc (Chief Medical Officer · Mar 14, 2006 – Sep 26, 2006 · Past) | Director · Sep 13, 2018 – Sep 28, 2020 · Past |
| John Smither Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); MBX Biosciences, Inc. (Chief Financial Officer · Since at least Mar 16, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Genelux Corporation (Chair, Compensation Committee · Since at least Sep 11, 2023); Applied Molecular Transport Inc (Director · Jan 27, 2022 – Dec 27, 2023 · Past); eFFECTOR Therapeutics Inc (Director · Aug 25, 2020 – Jun 22, 2023 · Past); Arcutis Biotherapeutics, Inc. (Chief Financial Officer · Jan 30, 2020 – Feb 13, 2024 · Past); Achaogen Inc (Director · Mar 11, 2014 – Jun 5, 2018 · Past); Kythera Biopharmaceuticals Inc (Chief Financial Officer · Oct 10, 2012 – Oct 1, 2015 · Past) | Director · Feb 19, 2019 – Feb 19, 2019 · Past |
| Shao-Lee Lin Other companies: Cue Biopharma, Inc. (President, Chief Executive Officer and Board Director · Since at least Apr 30, 2026); Acelyrin, Inc. (Chief Executive Officer, Director · May 4, 2023 – Apr 1, 2024 · Past); Third Harmonic Bio Inc. (Director · Sep 14, 2022 – Oct 26, 2022 · Past); Surrozen, Inc. (Director · Aug 11, 2021 – May 14, 2025 · Past); Horizon Pharma PLC (EVP, Head of R&D and CSO · Jan 4, 2018 – Feb 20, 2019 · Past) | Director · Apr 16, 2019 – Sep 28, 2020 · Past |
| Dan Becker Other companies: Zura Bio Limited (Director · Since at least May 21, 2025); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Day One Biopharmaceuticals Inc (Director · May 26, 2021 – Jun 22, 2023 · Past); Pandion Therapeutics Inc (Director · Jul 16, 2020 – Apr 1, 2021 · Past) | Director · Sep 13, 2018 – Sep 28, 2020 · Past |
| Dolca Thomas Other companies: Allakos Inc (Director · Jul 31, 2023 – May 15, 2025 · Past); Equillium, Inc. (Chief Medical Officer · Jan 11, 2021 – Jan 11, 2021 · Past); Aduro Biotech Inc (Director · Oct 5, 2020 – Aug 11, 2023 · Past) | Chief Medical Officer · Feb 12, 2019 – Sep 28, 2020 · Past |
| Roy Hardiman Other companies: Alumis Inc. (Chief Business and Strategy Officer · Since at least Jun 27, 2024); Pharmacyclics Inc (Director · Dec 9, 2010 – Oct 1, 2012 · Past) | Chief Business Officer · Sep 13, 2018 – Sep 28, 2020 · Past |
| Christopher Y Chai Other companies: Surrozen, Inc. (Director · Since at least Aug 11, 2021) | Chief Financial Officer · Sep 13, 2018 – Sep 28, 2020 · Past |
| David M Goldstein Other companies: Alumis Inc. (Chief Scientific Officer · Since at least Jun 27, 2024) | Chief Scientific Officer · Sep 13, 2018 – Sep 28, 2020 · Past |
| Lewis Shuster Other companies: Savara, Inc. (Director · Apr 8, 2011 – Jun 11, 2015 · Past) | Director · Sep 13, 2018 – Sep 13, 2018 · Past |
| Steve Gourlay | Chief Medical Officer · Sep 13, 2018 – Sep 18, 2018 · Past |